Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0X2JY
|
|||
| Former ID |
DIB005285
|
|||
| Drug Name |
Multiclade DNA recombinant adenovirus-5 (rAd5) vaccine
|
|||
| Synonyms |
Multiclade DNA recombinant adenovirus-5 (rAd5) vaccine (HIV-1 infection), Mbeya; (rAd5) vaccine
Click to Show/Hide
|
|||
| Indication | Human immunodeficiency virus-1 infection [ICD-11: 1C62; ICD-10: B20-B24] | Phase 1/2 | [1] | |
| Company |
Mbeya Medical Research Programme
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172). J Infect Dis. 2010 Feb 15;201(4):600-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.